Endurant Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-31,349
| Closed | -$2.33M | – | 66 |
|
|
2022
Q2 | $2.33M | Sell |
31,349
-15,091
| -32% | -$1.12M | 0.82% | 29 |
|
|
2022
Q1 | $4.17M | Sell |
46,440
-2,466
| -5% | -$222K | 1.1% | 24 |
|
|
2021
Q4 | $5.48M | Buy |
+48,906
| New | +$5.48M | 1.32% | 22 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 72 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 73 |
|
|
2017
Q4 | – | Sell |
-6,300
| Closed | -$545K | – | 90 |
|
|
2017
Q3 | $545K | Buy |
6,300
+3,000
| +91% | +$260K | 0.17% | 78 |
|
|
2017
Q2 | $255K | Sell |
3,300
-200
| -6% | -$15.5K | 0.07% | 91 |
|
|
2017
Q1 | $243K | Buy |
+3,500
| New | +$243K | 0.08% | 84 |
|